Cargando…
A meta-analytic evaluation of the correlation between event-free survival and overall survival in randomized controlled trials of newly diagnosed Ewing sarcoma
BACKGROUND: In randomized controlled trials (RCTs) of adjuvant treatment for malignant tumors, event-free survival (EFS) is considered the most acceptable surrogate for overall survival (OS). However, even though EFS has repeatedly been selected as a primary endpoint in RCTs of Ewing sarcoma (ES), t...
Autores principales: | Tanaka, Kazuhiro, Kawano, Masanori, Iwasaki, Tatsuya, Itonaga, Ichiro, Tsumura, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201711/ https://www.ncbi.nlm.nih.gov/pubmed/32370741 http://dx.doi.org/10.1186/s12885-020-06871-9 |
Ejemplares similares
-
Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation
por: Tanaka, Kazuhiro, et al.
Publicado: (2019) -
Surrogate endpoints for overall survival in randomised controlled trials of localised osteosarcoma: A meta-analytic evaluation
por: Tanaka, Kazuhiro, et al.
Publicado: (2020) -
MicroRNA-181c prevents apoptosis by targeting of FAS receptor in Ewing’s sarcoma cells
por: Kawano, Masanori, et al.
Publicado: (2018) -
Surrogacy analysis of intermediate end-points for overall survival in randomized controlled trials of rhabdomyosarcoma
por: Kubota, Yuta, et al.
Publicado: (2022) -
Tumor-suppressive microRNA-152 inhibits the proliferation of Ewing’s sarcoma cells by targeting CDK5R1
por: Kawano, Masanori, et al.
Publicado: (2023)